Man Group
INDV icon

Man Group’s Indivior Pharmaceuticals INDV Stock Holding History

Man Group’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Sell
7,051
-309,541
-98% -$11.2M ﹤0.01% 2177
2026
Q1 		$9.65M Buy
316,592
+216,021
+215% +$7.13M 0.02% 828
2025
Q4 		$3.61M Sell
100,571
-47,679
-32% -$1.46M 0.01% 1217
2025
Q3 		$3.57M Buy
+148,250
New +$3.1M 0.01% 1209
2025
Q1 		– Sell
-45,365
Closed -$564K – 2273
2024
Q4 		$564K Buy
45,365
+33,771
+291% +$347K ﹤0.01% 1635
2024
Q3 		$113K Buy
+11,594
New +$136K ﹤0.01% 1893

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group's INDV Position: Q2 2026 in Review

Man Group reduced its Indivior Pharmaceuticals (INDV) stake by 98% in Q2 2026, selling an estimated $11.2M and leaving 7,051 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #2177.

Man Group first reported a position in INDV in Q3 2024 and has held it in 6 quarters since. The position peaked at $9.65M in Q1 2026. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Man Group held 7,051 shares of Indivior Pharmaceuticals worth $289K as of Q2 2026.
  • Man Group sold 309,541 Indivior Pharmaceuticals shares in Q2 2026, an estimated $11.2M.
  • Indivior Pharmaceuticals made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2177 holding.
  • Man Group first reported a position in Indivior Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • Man Group's Indivior Pharmaceuticals position peaked at $9.65M in Q1 2026.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.